Slingshot members are tracking this event:

Jazz Pharma Top-line results from the Phase 3 TONES Studies of JZP-110 in Treatment of Excessive Sleepiness in Adults with Obstructive Sleep Apnea

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 20, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Zp-110, Tones 3, Tones 4, Osa, Obstructive Sleep Apnea